Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

Obesity: A Disease

Obesity Medicine에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Obesity Medicine 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

3y ago 35:27

MP3•에피소드 홈

저장한 시리즈 ("피드 비활성화" status)

When? This feed was archived on August 29, 2022 01:07 (1+ y ago). Last successful fetch was on July 09, 2022 08:32 (2y ago)

Why? 피드 비활성화 status. 잠시 서버에 문제가 발생해 팟캐스트를 불러오지 못합니다.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 - Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guests

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

Resources Mentioned

Anti-Obesity Medications in the Pipeline Lecture

71 에피소드

#Fitness #Medicine #Obesity A Disease